Benztropine Should Not Be Used to Treat Catatonia
Benztropine is an anticholinergic agent indicated for drug-induced extrapyramidal symptoms and parkinsonism—not for catatonia treatment. In fact, using benztropine in catatonia could be harmful, as anticholinergic medications should generally be avoided in this condition.
Why Benztropine Is Not Appropriate for Catatonia
Wrong Mechanism of Action
Benztropine possesses anticholinergic and antihistaminic properties 1. The FDA-approved indications are specifically for:
- Drug-induced extrapyramidal disorders (dystonia, parkinsonism, akathisia)
- Idiopathic and postencephalitic parkinsonism 1
There is no FDA indication or guideline support for using benztropine to treat catatonia itself.
Critical Distinction: Catatonia vs. Extrapyramidal Side Effects
Guidelines explicitly warn that differentiating between drug-induced parkinsonism and catatonia can be difficult 2. This is a common clinical pitfall. If a patient on antipsychotics develops what appears to be catatonia, the issue may actually be:
- Severe drug-induced parkinsonism (which benztropine treats)
- Neuroleptic malignant syndrome (which requires immediate intervention)
- True catatonia (which requires benzodiazepines or ECT)
The key caveat: Benztropine may help if the "catatonia-like" presentation is actually severe extrapyramidal symptoms from antipsychotic medications, but this represents treating a side effect, not treating catatonia.
Established Treatments for Catatonia
First-Line: Benzodiazepines
Lorazepam is the gold standard for acute catatonia treatment 3, 4, 5, 6. The evidence shows:
- 77% overall response rate and 55% remission rate 3
- Typical dosing: 2-60 mg/day (median 8 mg/day) 3
- Effect size of -11.88 points on the Bush Francis Catatonia Rating Scale (Cohen's d = -3.15) 3
- Treatment duration typically does not exceed 1 week for acute response 3
Second-Line: Electroconvulsive Therapy (ECT)
ECT is indicated when 7:
- Benzodiazepines fail or cannot be tolerated
- The patient has life-threatening symptoms (refusal to eat/drink, severe suicidality)
- Catatonia is associated with neuroleptic malignant syndrome 7
ECT is considered the treatment of choice for catatonia in pregnancy, neuroleptic malignant syndrome, and when medications are contraindicated 8, 7.
Clinical Algorithm for Suspected Catatonia
- Confirm diagnosis using Bush Francis Catatonia Rating Scale or similar validated tool
- Rule out medical causes and complications (autonomic instability, dehydration, rhabdomyolysis)
- Discontinue or reduce antipsychotics if present—they may be contributing
- Start lorazepam 1-2 mg IV/IM for rapid assessment (positive response within hours supports diagnosis)
- Titrate lorazepam to 6-16 mg/day in divided doses based on response
- Consider ECT if no response after 3-5 days of adequate benzodiazepine trial
- Avoid anticholinergics like benztropine unless treating concurrent extrapyramidal symptoms
The One Exception: Drug-Induced Pseudo-Catatonia
The single case report showing benztropine "resolving catatonia" 9 actually describes a patient on chronic fluphenazine who overdosed on phenylpropanolamine. The "catatonic symptoms" rapidly resolved with benztropine, suggesting this was likely severe drug-induced extrapyramidal symptoms mimicking catatonia, not true catatonia. This reinforces the diagnostic challenge rather than supporting benztropine for catatonia treatment.
Important Safety Considerations
Guidelines specifically caution against using anticholinergics like benztropine in elderly patients with cognitive impairment or Alzheimer's disease due to worsening confusion and delirium 10. Since catatonia can occur in these populations, benztropine would be particularly inappropriate.
Bottom line: Use lorazepam (or another benzodiazepine) as first-line treatment for catatonia, with ECT as second-line. Reserve benztropine exclusively for treating antipsychotic-induced extrapyramidal symptoms, not catatonia itself.